Safety Data SheetChemical Risk Assessment

Votrient Tablets

by GlaxoSmithKline

SDS · PDF, approx. 220 KB CRA · PDF, approx. 180 KB

Votrient Tablets is supplied by GlaxoSmithKline under product code VOTRIENT TABLETS 50 MG, VOTRIENT TABLETS 100 MG, VOTRIENT TABLETS 200 MG, VOTRIENT TABLETS 400 MG, VOTRIENT TABLETS 500 MG, GW786034B TABLETS, PAZOPANIB HYDROCHLORIDE, FORMULATED PRODUCT. This page provides both the Safety Data Sheet (SDS) and the Chemical Risk Assessment (CRA) for this substance, under GHS/CLP regulations for UK workplace use under COSHH. The full SDS and CRA documents are available to download above.

This SDS was last revised on 21 May 2018. The matching CRA is updated in line with SDS revisions. Workplaces handling this substance should retain a current SDS and risk assessment for the duration of use.


Language
English
Regulation
GHS/CLP
Revision Date
21 May 2018
Signal Word
WARNING
Product Code
VOTRIENT TABLETS 50 MG, VOTRIENT TABLETS 100 MG, VOTRIENT TABLETS 200 MG, VOTRIENT TABLETS 400 MG, VOTRIENT TABLETS 500 MG, GW786034B TABLETS, PAZOPANIB HYDROCHLORIDE, FORMULATED PRODUCT
CAS Number
635702-64-6,9004-34-6,9063-38-1,9003-39-8,68130-99-4,557-04-0,13463-67-7

Switch between the Safety Data Sheet and the Chemical Risk Assessment for this substance.

Hazards at a GlanceFrom the Safety Data Sheet
Signal Word: WARNING

Hazard Statements (H-phrases)
+548+EEC
See full Safety Data Sheet for the hazard statement wording.

Need the full hazard breakdown? Precautionary statements, first aid, physical properties and exposure controls are in the full SDS PDF.


Common QuestionsAbout this Safety Data Sheet

Need help with Safety Data Sheets? You've come to the right place!

CONTACT US